Form 4: Fulgent Genetics CEO Ming Hsieh Reports Stock Transaction
SEC Form 4 Filing
Fulgent Genetics CEO Ming Hsieh reports the withholding of shares to cover tax obligations and details beneficial ownership through various trusts and custodial accounts.
Summary
- On November 1, 2024, Ming Hsieh, CEO of Fulgent Genetics, reported a transaction involving common stock.
- 1,337 shares were withheld to satisfy tax obligations related to vesting restricted stock units granted on August 1, 2022.
- Following the transaction, Hsieh directly owns 705,938 shares.
- Hsieh also has indirect ownership through the Dynasty Trust (220,816 shares), the Ming Hsieh Trust (7,895,115 shares), and Uniform Transfer to Minors Accounts (2,000 shares).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a routine stock transaction, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it primarily reflects internal tax obligations of the CEO.
Key Dates
| Date | Description |
|---|---|
| 08/01/2022 | Date of restricted stock units grant. |
| 08/03/2022 | Date of original Form 4 filing for the restricted stock units grant. |
| 11/01/2024 | Date of the reported stock transaction (tax withholding). |
| 11/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.